IV
Inventiva S.A.
IVEVF · OTC
$3.59 +0.00% (+$0.00)
Market Cap 734.1M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 163.82x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 28.34%
EPS growth N/A
Book val. growth N/A
Profitability
14 /100
Weak Gross margin 35.07%
FCF margin 2,345.98%
Net margin 7,899.58%
Quality
0 /100
Poor ROIC 64.58%
Asset turnover 0.02x
ROA 141.88%
Debt
43 /100
Moderate Current ratio 3.16x
Int. coverage -4.06x
Debt/Equity N/A
Stability
32 /100
Unstable Beta 0.91x
Profitable years 0
Rev. volatility 56.55%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IVEVF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Obenshain
Employees
77
Headquarters
Daix
Prihajajoči dogodki
28 SEP.
Earnings
Upcoming earnings report